問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Linkou Chang Gung Medical Foundation
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2021-06-01 - 2022-05-30
Condition/Disease
Test Drug
Participate Sites6Sites
Recruiting6Sites
2020-10-20 - 2022-04-28
Participate Sites4Sites
Not yet recruiting2Sites
Recruiting2Sites
2020-04-27 - 2022-04-27
Insomnia Disorder
Lemborexant
Participate Sites2Sites
2021-02-03 - 2024-01-25
generalized myasthenia gravis
Rozanolixizumab
Participate Sites5Sites
Not yet recruiting3Sites
Recruiting1Sites
Study ended1Sites
2021-04-01 - 2022-09-30
Primary Immune Thrombocytopenia
Participate Sites8Sites
Not yet recruiting8Sites
2020-07-01 - 2024-01-03
Participate Sites1Sites
2019-09-01 - 2021-09-30
2018-12-31 - 2020-12-31
Skin Rash in Subjects with EGFR Inhibitor Therapy
AC-701(Berberine) Gel:0.3%
2008-01-01 - 2011-03-31
Terminated6Sites
2012-07-01 - 2020-06-30
Participate Sites11Sites
Terminated11Sites
全部
